Georgia Congressman Buddy Carter (R-GA-01) is making another attempt to limit the power of pharmacy benefit managers (PBMs) “to artificially spike Medicaid drug prices.” Carter joined Rep. Vicente Gonzalez (D-TX) in re-introducing the bi-partisan Drug Price Transparency in Medicaid Act. The bill was first introduced in 2019 by Carter during the 116th Congress with bipartisan support.

U.S. Rep. Buddy Carter

According to Carter, the only pharmacist in the U.S. House, this legislation bans the use of spread pricing by middlemen (PBMs) in Medicaid managed care. PBMs drive up prescription drug costs without adding any value to the consumer, Carter says. 

Please enter your User Name and Password to view the rest of this subscriber-only story. If you are unable to login, your account may have expired. Please contact James Online if you have any problems.




Lost your password?